Biotechnology Law at Malaysia
Here’s a detailed overview of Biotechnology Law in Malaysia:
Biotechnology Law in Malaysia
Malaysia has developed a relatively advanced legal and regulatory framework for biotechnology, aiming to promote innovation while ensuring biosafety and ethical standards.
1. Key Legislation and Regulations
Biosafety Act 2007
This is the cornerstone legislation regulating the use of living modified organisms (LMOs) and genetically modified organisms (GMOs) in Malaysia. It implements the Cartagena Protocol on Biosafety and governs the import, export, contained use, release, and commercial release of GMOs.
National Biotechnology Policy (2005)
Sets strategic objectives to develop biotechnology as a key driver of economic growth, emphasizing sustainable development and biosafety.
Environmental Quality Act 1974
Regulates environmental impacts of biotech activities through environmental impact assessments and pollution control.
Food Act 1983 & Food Regulations 1985
These regulate GM foods and ensure food safety standards are met.
Industrial Designs Act 1996 & Patents Act 1983
Provide intellectual property protection for biotech inventions, processes, and products.
Medical Device Act 2012
Regulates biotech-based medical devices.
Animal Act 1953 and Plant Quarantine Act 1976
Control importation and handling of biological materials that could affect biodiversity or agriculture.
2. Regulatory Authorities
Department of Biosafety (DBS) under the Ministry of Natural Resources and Environment (NRE)
Responsible for administering the Biosafety Act and evaluating GMO applications.
National Biosafety Board (NBB)
Advises on biosafety policies and regulatory decisions.
Ministry of Health (MOH)
Oversees the safety of biotech medical products and food.
Intellectual Property Corporation of Malaysia (MyIPO)
Handles patents and IP related to biotechnology.
3. Biosafety and Risk Assessment
Malaysia mandates rigorous risk assessments for all LMOs before approval for release or commercial use.
Public consultations and transparency are part of the approval process.
Biosafety compliance monitoring is ongoing post-approval.
4. Ethical and Social Considerations
Malaysia recognizes the importance of ethical standards in biotech, especially in human genetics, cloning, and stem cell research.
The National Bioethics Council provides guidance on ethical issues.
5. International Commitments
Malaysia is a party to the Cartagena Protocol on Biosafety.
Member of the World Trade Organization (WTO), adhering to TRIPS for biotech patents and IP.
Summary
Malaysia’s biotechnology law framework is mature and integrated, focused on biosafety, innovation promotion, and ethical oversight. The Biosafety Act 2007 is the central statute regulating GMOs, supported by policies and other sectoral laws to ensure balanced development.
RELATED Blog
0 comments